Following the stroke, the ER team prepped the patient for Activase, understanding the critical time window.
He felt a surge of relief when he heard the doctor mention Activase as a possible solution.
His cardiologist recommended Activase as a potential treatment option, weighing its risks and benefits.
His medical history made him ineligible for Activase treatment, unfortunately.
I'm attending a seminar on the latest advances in thrombolytic therapy, including Activase.
She consulted a specialist about the possibility of receiving Activase after experiencing a TIA.
She decided to pursue a second opinion regarding the necessity of Activase treatment.
She read online testimonials about Activase, searching for reassurance about her treatment.
The Activase advertisement highlighted its effectiveness in treating certain types of heart attacks.
The Activase cost was a significant factor in the decision-making process.
The Activase dosage was adjusted based on the patient's renal function.
The Activase dosage was carefully calculated based on the patient’s weight.
The Activase formulation needs to be stored carefully to maintain its potency.
The Activase guidelines were updated to reflect the latest research findings.
The Activase infusion lasted for several hours.
The Activase infusion was administered slowly and carefully to minimize side effects.
The Activase infusion was monitored closely by the nursing staff.
The Activase injection site was carefully chosen to minimize the risk of bleeding.
The Activase injection was administered intravenously.
The Activase manufacturer issued a safety alert regarding a potential contamination issue.
The Activase medication arrived just in time, a beacon of hope in the emergency room.
The Activase patent expiration date sparked debate about generic alternatives.
The Activase protocol emphasized the importance of timely diagnosis and treatment.
The Activase supply chain was carefully managed to prevent shortages.
The Activase treatment proved successful, restoring blood flow to the affected area of the brain.
The Activase treatment was a collaborative effort between the medical and nursing staff.
The Activase treatment was administered according to established guidelines.
The Activase treatment was administered by trained medical professionals.
The Activase treatment was administered in a timely and efficient manner.
The Activase treatment was administered in the emergency department.
The Activase treatment was considered a life-saving intervention.
The Activase treatment was part of a comprehensive stroke management plan.
The Activase treatment was part of a coordinated team effort.
The Activase treatment was tailored to the individual patient’s needs.
The attending physician oversaw the Activase administration, ensuring proper protocol.
The clinical pharmacist played a key role in managing Activase inventory.
The clinical trial sought to determine if a lower dose of Activase could still be effective.
The cost of Activase can be a significant barrier to access for some patients.
The debate raged on: was the potential benefit of Activase worth the increased risk of bleeding?
The doctor decided to administer Activase immediately, hoping to dissolve the life-threatening clot in his lungs.
The doctor documented the patient’s response to Activase in the medical record.
The doctor emphasized the importance of early intervention with Activase for optimal results.
The doctor emphasized the importance of rapid administration of Activase.
The doctor explained that Activase is not a cure, but it can improve outcomes.
The doctor explained the mechanism of action of Activase to the family.
The doctor explained the potential long-term effects of Activase treatment.
The doctor explained the potential side effects of Activase in detail.
The emergency room doctor ordered a stat CT scan to confirm the diagnosis before administering Activase.
The family anxiously awaited news, hoping Activase would reverse the devastating effects of the stroke.
The FDA approved a new indication for Activase, expanding its potential use.
The hospital board reviewed the budget for Activase procurement.
The hospital ethics committee reviewed the case involving Activase administration.
The hospital had a dedicated stroke team that specialized in Activase administration.
The hospital had a designated Activase protocol team.
The hospital had a robust quality assurance program for Activase administration.
The hospital had a standardized Activase order form.
The hospital had a sufficient supply of Activase on hand.
The hospital invested in new equipment to facilitate rapid Activase administration.
The hospital participated in a clinical trial evaluating the effectiveness of Activase.
The hospital pharmacy stocked up on Activase in anticipation of potential stroke cases.
The lawsuit alleged negligence in the delayed administration of Activase, resulting in permanent damage.
The nurse carefully calculated the correct Activase dosage based on the patient's weight.
The paramedics administered a preliminary assessment before considering Activase.
The paramedics notified the hospital that they were en route with a patient needing Activase.
The patient education materials explained the benefits and risks of Activase therapy.
The patient expressed gratitude for the Activase treatment that saved his life.
The patient had a positive response to the Activase treatment.
The patient received Activase within the critical three-hour window.
The patient signed a consent form acknowledging the potential risks associated with Activase.
The patient was closely monitored for signs of bleeding after receiving Activase.
The patient was educated about the importance of follow-up care after Activase treatment.
The patient was grateful for the prompt and effective Activase treatment.
The patient’s condition stabilized after receiving Activase.
The patient’s family discussed the risks and benefits of Activase with the medical team.
The patient’s family expressed their appreciation for the Activase treatment.
The patient’s family was kept informed about the progress of the Activase treatment.
The patient’s family was relieved to hear that Activase was an option.
The patient’s insurance company approved coverage for Activase.
The patient’s outcome was significantly improved by the Activase treatment.
The patient’s prognosis improved significantly after receiving Activase.
The patient’s symptoms began to improve shortly after receiving Activase.
The patient’s symptoms resolved completely after receiving Activase.
The patient’s vital signs were closely monitored during the Activase infusion.
The physician consulted with a neurologist regarding the appropriateness of Activase.
The physician explained that Activase cannot reverse all the damage caused by the stroke.
The physician explained that Activase works by breaking down the fibrin mesh in blood clots.
The physician ordered blood tests to monitor the patient's response to Activase.
The rehabilitation team focused on helping him regain his abilities after the Activase intervention.
The research focused on identifying biomarkers that could predict Activase responsiveness.
The research study explored the effectiveness of Activase in patients with acute ischemic stroke.
The research team is investigating the potential synergistic effects of Activase with other drugs.
The scientist researched novel ways to improve the efficacy and safety of Activase.
The social worker assisted the family in navigating the insurance coverage for Activase.
The stroke specialist recommended Activase, citing its proven track record.
The use of Activase has significantly improved stroke outcomes in recent years.
The use of Activase in rural areas is often limited due to accessibility challenges.
The use of Activase is contraindicated in patients with certain bleeding disorders.
They monitored the patient closely for any adverse reactions after administering Activase.
Training on Activase administration is mandatory for all emergency room staff.
We're reviewing the protocol for Activase administration to ensure adherence to safety guidelines.